Kortylewski Marcin 13D and 13G filings for Scopus BioPharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-07-12 8:20 pm Purchase | 2021-06-25 | 13G | Scopus BioPharma Inc. SCPS | Kortylewski Marcin | 911,079 5.000% | 911,079 (New Position) | Filing |